PVI
EOLS icon

Pura Vida Investments’s Evolus EOLS Stock Holding History

Pura Vida Investments’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-294,500
Closed -$1.15M – 196
2020
Q3 		$1.15M Buy
294,500
+212,600
+260% +$777K 0.06% 127
2020
Q2 		$434K Buy
+81,900
New +$377K 0.04% 116

Other funds holding EOLS

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Pura Vida Investments's EOLS Position: Q1 2023 in Review

Pura Vida Investments sold out of Evolus (EOLS) in Q1 2023, closing a stake of 50,000 shares — an estimated $376K sold.

Pura Vida Investments first reported a position in EOLS in Q1 2018 and held it in 4 quarters. The position peaked at $2.38M in Q4 2019. 125 funds tracked by Wall St. Rank hold EOLS as of Q1 2023.

  • Pura Vida Investments reported no remaining Evolus position as of Q1 2023 after selling out during the quarter.
  • Pura Vida Investments sold 50,000 Evolus shares in Q1 2023, an estimated $376K.
  • Pura Vida Investments first reported a position in Evolus in Q1 2018 and held it in 4 quarters.
  • Pura Vida Investments's Evolus position peaked at $2.38M in Q4 2019.
  • 125 funds tracked by Wall St. Rank held Evolus as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.